A Novel Glycerophosphodiester Phosphodiesterase, GDE5, Controls Skeletal Muscle Development via a Non-enzymatic Mechanism

作者：Okazaki Yuri; Ohshima Noriyasu; Yoshizawa Ikumi; Kamei Yasutomi; Mariggio Stefania; Okamoto Keiko; Maeda Masahiro; Nogusa Yoshihito; Fujioka Yuichiro; Izumi Takashi; Ogawa Yoshihiro; Shiro Yoshitsugu; Wada Masanobu; Kato Norihisa; Corda Daniela; Yanaka Noriyuki^*

来源：JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285(36): 27652-27663.

DOI：10.1074/jbc.M110.106708

Mammalian glycerophosphodiester phosphodiesterases (GP-PDEs) have been identified recently and shown to be implicated in several physiological functions. This study isolated a novel GP-PDE, GDE5, and showed that GDE5 selectively hydrolyzes glycerophosphocholine (GroPCho) and controls skeletal muscle development. We show that GDE5 expression was reduced in atrophied skeletal muscles in mice and that decreasing GDE5 abundance promoted myoblastic differentiation, suggesting that decreased GDE5 expression has a counter-regulatory effect on the progression of skeletal muscle atrophy. Forced expression of full-length GDE5 in cultured myoblasts suppressed myogenic differentiation. Unexpectedly, a truncated GDE5 construct (GDE5 Delta C471), which contained a GP-PDE sequence identified in other GP-PDEs but lacked GroPCho phosphodiesterase activity, showed a similar inhibitory effect. Furthermore, transgenic mice specifically expressing GDE5 Delta C471 in skeletal muscle showed less skeletal muscle mass, especially type II fiber-rich muscle. These results indicate that GDE5 negatively regulates skeletal muscle development even without GroPCho phosphodiesterase activity, providing novel insight into the biological significance of mammalian GP-PDE function in a non-enzymatic mechanism.

• 出版日期2010-9-3